Why Attend
Reproductive health is set to hold a leading market share of women’s health industry, with an estimated global worth of $171 billion by 2027.
Start-ups, Femtech, and Technology innovators are driving the acceleration of new and improved solutions for the unmet needs of people’s reproductive health journeys.
The Reproductive Health Innovation Summit (15-16 February) is the destination for uncovering what is next in fertility, contraception, and maternal health, from AI and big data to genetic testing, laboratory automation, consumer wearables, non-hormonal devices and solutions, and new care delivery models.
Join us to:
- Tackle the challenges that straddle the reproductive health sector, including funding, insurance coverage, access and DTC business-models.
- Dive into 1 of our 3 leading innovation topics: Contraception, Fertility or Maternal Health, to discover the latest research, innovations, and sector-specific challenges and opportunities.
- Network with the leaders and changemakers, with numerous 1-2-1 opportunities, investor clinics and interactive roundtables throughout the 2 days.
Add to the innovation, and attend alongside our leading network of, biotech’s, start-ups, Femtech, insurers, CRO’s, investors, medical device companies, researchers, pharmaceuticals, HCP’s and advocacy groups, to drive innovation at the convergence of healthcare and technology.
2022 Innovation Spotlight
Showcasing the most innovative and disruptive companies in reproductive health.
18 opportunities at this years’ summit!
9 reproductive health focused start-ups, selected by our prestigious Selection Committee, will take to the stage in quick-fire round of presentations, demonstrating their vision of the reproductive health industry of the future, and what role their technology, product, or service plays in that.
3 finalists will be selected from each of the 3 innovation categories: contraception, fertility and maternal health, to give a 3-minute pitch of their company in front of 100s of industry leaders and strategic, corporate partners.
The 3 runners-up in each category will have the opportunity to enter a ‘lightening round’ of 1- minute pitches on-stage.
Applications are stage agnostic, and we encourage anyone to apply with a vision of a better reproductive health industry of the future.
All details shared with the committee are strictly confidential. The more detailed application form, the more information the selection committee can use to make their decision. However, if you do not wish to fill in a question, please feel free to leave it blank.
FINALISTS ANNOUNCED
Click here to see who they are!
2022’S PRESTIGIOUS SELECTION COMMITTEE OF INVESTORS
2022 Partners
Platinum Partner
Presagen
Website: https://www.presagen.com/
Presagen is an AI healthcare company focused on improving Women's health outcomes globally. Presagen's Social Network for Healthcare that is changing the way clinics, patients, and medical data from around the world are connected through AI. Our online data-sharing and collaboration network enables clinics and patients to connect, safely share data, use AI healthcare services, and get rewarded. With an initial focus in Women’s Health, Presagen’s first product, Life Whisperer, is being used by IVF clinics globally to improve pregnancy outcomes for patients.
Organon
Website: https://www.organon.com/
Organon (NYSE: OGN) is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets. Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,000 employees with headquarters located in Jersey City, N.J.
Cambridge Design Partnership
Website: https://www.cambridge-design.com/
Please visit our website for more information.Gold Partner
ICON PLC
Website: https://iconplc.com/
ICON plc is a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON employs approximately 16,000 employees in 93 locations in 41 countries. Further information is available at www.iconplc.com.
Granata Bio
Website: https://www.granata.bio/
Granata Bio is a biopharma company focused on women's health and infertility. Founded in 2018, Granata Bio’s model is to identify and in-license strategic products for development and commercialization in North America. The company recently announced a partnership with IBSA Group (Lugano, CH) to co-develop a novel subcutaneous progesterone solution in the United States.
For more information, please visit www.granata.bio. Follow on Twitter, Instagram, and LinkedIn.
Axia WH
Website: https://axiawh.com/
Axia Women's Health is leading the way in improving women's health. At the core of achieving this is a caring, connected, and progressive community of more than 400 providers and nearly 200 women's health centers across Pennsylvania, New Jersey, Indiana, Ohio, and Kentucky. The rapidly growing network spans OB/GYN physicians, breast health centers, high-risk pregnancy centers, a central laboratory, urogynecology, and fertility centers. Together, Axia Women's Health puts women first by delivering the personalized care needed for women to lead healthier, happier lives.
Nixon Peabody LLP
Website: https://www.nixonpeabody.com/en
Nixon Peabody LLP is a full-service law firm with 600 attorneys across 16 locations throughout the United States as well as in China and London. Our diverse platform offers clients the right combination of local resources and international experience. We deliver sophisticated legal services to our clients and our communities by combining high performance, entrepreneurial spirit, deep engagement, and an unwavering commitment to a culture of collaboration, diversity, and humanity. Specifically, our Healthcare Group is viewed as a top legal competitor across the industry, serving as a trusted advisor as we guide clients strategies for health care delivery, corporate organization, government programs, emerging payment programs, managed care models, and more. We partner with organizations across all sectors of the healthcare industry, on a range of services, including ancillary and specialty services, corporate transactions, digital health, financing, government investigations, health care litigation, health information management and privacy, network formation, regulatory compliance, and reimbursement and value-based contracting.
Media Partners
Women of Wearables
Website: https://www.womenofwearables.com/
Women of Wearables is the first global organisation that supports and connects women in wearable tech, fashion tech, health tech, IoT and VR/AR.
Its mission is to encourage more women and diverse teams to participate in building hardware and software products as designers, product managers and developers or being founders of their own companies, as well as create more jobs for women in STEM. With headquarters in London (UK) and more than 20,000 members located around the globe, WoW supports its growing community of women and girls in the tech space through monthly meetups, panels, mentorship and collaboration with its network of local ambassadors, partners and communities. WoW is not just for professional women, but for anyone with an interest in emerging technologies and providing women with a platform for growth.
FemTech Focus
Website: www.femtechfocus.org
Femtech Focus is a 501c3 non-profit entity empowering the femtech industry through increased awareness of femtech in the tech world, providing resources to femtech founders, and creating opportunities to support femtech startups through exposure, networking, and access to capital.
How we are contributing to women's health space:
Femtech Focus has a popular podcast with thousands of listeners around the world. This supports our efforts to increase awareness of the femtech industry.
Femtech Focus is launching a femtech accelerator this Fall. Follow our social pages and subscribe to our newsletter to know when applications open!
@FemtechFocus - Facebook, Twitter, Instagram, Linkedin
Expanding Medication Abortion Access (EEMA)
Website: https://emaaproject.org/
The EMAA Project seeks to improve the way the medications prescribed for medication abortion care are dispensed in the United States, to make the process consistent with the medical and scientific evidence and to meet women’s needs
Femtech Insider
Website: https://femtechinsider.com/
Femtech Insider is the go-to platform for all things femtech. We’re the fastest growing portal for innovation in women’s health and address the information needs of founders, investors, researchers and consumers alike.
Springboard
Website: https://sb.co
Springboard’s mission is to accelerate the growth of entrepreneurial companies led by women through access to essential resources and a global community of experts. We are a leading network of influencers, investors and innovators dedicated to building high-growth companies led by women who are transforming industries in technology and life science.
2022 Speakers
Elena Gambon
Alice Zheng, MD, MBA, MPH
David Sable
Elizabeth Garner
Ru-fong Joanne Cheng
Edio Zampaglione
Kelle Moley, MD
Dr. Kelle Moley is a career physician-scientist obstetrician/gynecologist who currently leads the Reproductive Health Technologies Domain within the Discovery & Translational Sciences, Global Health Division at the Bill and Melinda Gates Foundation. Kelle joined BMGF in July 2020, with a 30-year history of basic and translational research on reproductive health issues in females throughout the life course-- from organismal to cellular and molecular levels of metabolic, developmental biology, embryo implantation and decidualization, and infectious diseases of the female reproductive tract.
Kelle earned her BA from Wellesley College, and her MD from Yale Medical School. Thereafter, she pursued an Obstetrics & Gynecology Residency and a Fellowship in Reproductive Endocrinology & Fertility at Washington University in St. Louis School of Medicine. Kelle then spent the next 3 decades of a thriving research career at Washington University—rising to become the James P. Crane Professor of Obstetrics & Gynecology, Vice Chair of Obstetrics & Gynecology, Chief of the Division of Basic & Translational Research for the Department of Obstetrics & Gynecology, Co-Director of the Institute of Clinical & Translational Science for the School of Medicine, and Director of the Center for Reproductive Health Sciences at the School of Medicine. Her research (published in some 150 peer-reviewed primary articles) led to an international reputation along with numerous honors, including election to the National Academy of Medicine in 2014. She also earned a reputation as a superb mentor to trainees, leading the reproductive endocrinology fellowship program at Washington University until she left academia in 2018. After a 2-year stint as Chief Scientific Officer and Senior Vice President of the March of Dimes she left to pursue her new position at BMGF.
Katie Williams
Mikayla Johnson
Dr. Raoul Scherwitzl
Nathanial DeNicola
Dr. Patrick Carroll
Akash Bakshi
Lisa Campo-Engelstein
Sasha Ottey, MHA, MT, (ASCP)
Shelley Alpern
Amanda Gorman
Sara Naseri
Reenita Das
Katie Schubert
Jamie White
Heather Vahdat
Thomas Crouzier
Priyanka Jain
Anula Jayasuriya
Audrey Anderson Duckett
Brian T. Nguyen
Elizabeth Bailey
Linda Greub
Deena Shakir
Maria Velissaris
Jackie Rotman
Evan Sussman
Michelle Perugini
Rachel Scherl
Rachel Blank
Dr. Neel Shah
Alison Malmqvist
Emma Kemble
Amy Fan
Bruno van Tuykom
Sarah Cairns-Smith
Carli Sapir
Polly Rodriguez
Lauren Wang
Dr. Rem Koning
Dana Northcraft
Vrunda Desai
Dr. Denny Sakkas
Dr.Lynn Wesphal
Dr. Barbara Stegmann
Dr. Elizabeth Cherot
Dr. Kristyn Brandi
Melissa Grant
Monica Lee
Sarah Swank
As a former senior in-house counsel for two national health care systems, Sarah Swank provides strategic, regulatory and operational advice to health systems, hospitals and academic medical centers, as well as large national and regional physician organizations and telehealth and other startups.
Alexandra Busto
Alexandra Busto is an associate in the Health Care group. She works with academic medical centers, hospitals, long-term care facilities, surgery centers, foundations and clinics, medical groups/IPAs, accountable care organizations, and other entities affiliated with the health care industry. Alex also represents companies in the health information, medical device, and telehealth fields.
Download 2022 agenda
Be the first to view our 2021 Reproductive Health Innovation Summit agenda!
Sessions include:
- Investment, Innovation & Reproductive Health: Where does Technology Stand today?
- The IVF Clinic Market of the Future: Exploring the Impact of PE investment
- Male Reproductive Health & The Impact on Women's Health
- Sex & Gender in Medicine, Research & Practice
Our agenda provides all the information you need to book your place at Reproductive Health Innovation Summit USA, access your copy today!
Download the Reproductive Health Innovation Summit Agenda
Returning Safely Measures
Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.
All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.
Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.
Covid-19 Update for attending Reproductive Health Innovation Summit, February 15th – 16th 2022
As of January 15th, 2022, a Covid-19 vaccination mandate will come in to affect in the city of Boston. This mandate means that anyone attending an event must be double vaccinated and provide proof of this prior to attending the event. Anyone with a medical or religious exemption is not permitted to attend any event in line with the Boston city mandate. Further details on the Covid-19 vaccination mandate can be found by clicking here.
The Boston Park Plaza hotel will be enforcing this for any event taking place within their hotel. For more information on what the Boston Park Plaza are doing to ensure the safety of guests and visitors to the hotel click here.
To ensure we meet all mandate and hotel rules, we will be asking anyone attending the Reproductive Health Innovation Summit to be double vaccinated and to provide proof of this by sending us a copy of your vaccination card via email. Anyone who is not double vaccinated will not be permitted to attend; as the venue will not accept testing in lieu of vaccination, and in line with the city of Boston mandate.
REGISTRATION
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Registration ends in
VENUE
Venue
50 Park Plaza, Boston, MA 02116, United States
Please use our booking link here, to book your hotel room at our preferential rate.
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.